10-Year Outcomes Similar for H-IMRT, C-IMRT in Prostate Cancer

MONDAY, March 23, 2020 -- For men with intermediate- and high-risk prostate adenocarcinoma, 10-year outcomes are similar with conventionally fractionated intensity-modulated radiation therapy (C-IMRT) or moderate hypofractionated IMRT (H-IMRT),...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news